- Investing Ideas
- /
- Global Pure Equity Growth
Global Pure Equity Growth
Results
181
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
181 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
S1GE34 | US$56.70 | 6.7% | n/a | US$43.2b | US$56.74 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
1AE | €490.30 | 2.5% | 7.5% | €29.0b | €516.23 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
0QW0 | €487.57 | 2.5% | 7.8% | €29.0b | €513.36 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGN.F | €525.60 | 0% | n/a | €29.0b | €553.40 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €485.10 | 0.6% | 7.3% | €29.0b | €510.75 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGXB | €481.80 | 0% | 5.3% | €29.0b | €507.28 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGX N | €8,484.05 | 0% | n/a | €29.0b | €8,932.69 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
A1RG34 | €120.12 | 4.1% | 19.5% | €29.0b | €126.47 | PS19.5x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
1AEA | €360.00 | 0% | -26.2% | €28.8b | €381.55 | PS19.3x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €524.58 | -2.2% | 7.9% | €28.5b | €562.17 | PS19.2x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €483.30 | 1.2% | 5.7% | €28.5b | €517.93 | PS19.2x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
1AEA | €488.00 | 3.4% | 8.0% | €28.5b | €522.97 | PS19.2x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$51.57 | 3.7% | 96.6% | US$16.1b | US$50.28 | PE90.7x | E24.2% | n/a | Consumer Durables | ||
DUOL | US$277.96 | 5.3% | 74.7% | US$12.5b | US$252.82 | PE182.7x | E41.6% | n/a | Consumer Services | ||
300502 | CN¥109.97 | 12.4% | 139.1% | CN¥77.9b | CN¥119.30 | PE61.6x | E42.5% | 0.1% | Tech | ||
300502 | CN¥109.97 | 12.4% | 139.1% | CN¥77.9b | CN¥119.30 | PE61.6x | E42.5% | 0.1% | Tech | ||
735 | HK$5.75 | 3.6% | 103.9% | HK$68.4b | HK$6.00 | PE40.4x | E29.3% | 0.6% | Retail | ||
9992 | HK$51.60 | 5.4% | 127.8% | HK$68.4b | HK$53.85 | PE40.4x | E29.3% | 0.6% | Retail | ||
9992 | HK$51.60 | 5.4% | 127.8% | HK$68.4b | HK$53.85 | PE40.4x | E29.3% | 0.6% | Retail | ||
9992 | HK$51.60 | 5.4% | 127.8% | HK$68.4b | HK$53.85 | PE40.4x | E29.3% | 0.6% | Retail | ||
A042700 | ₩114,200.00 | 18.7% | 116.7% | ₩11.0t | ₩188,857.14 | PE69.6x | E46.2% | 0.4% | Semiconductors | ||
23I | US$66.50 | -1.5% | 30.1% | US$7.9b | US$85.96 | PS13.9x | E64.4% | n/a | Pharmaceuticals & Biotech |